These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 6944596)
21. Acute leukaemia of adults in Auckland: biological characteristics and survival. Buchanan JG; Bensley KE N Z Med J; 1969 Jul; 70(446):1-6. PubMed ID: 5258863 [No Abstract] [Full Text] [Related]
22. Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: comparison with adult acute myeloid leukemia. Verstovsek S; Manshouri T; Smith FO; Giles FJ; Cortes J; Estey E; Kantarjian H; Keating M; Jeha S; Albitar M Cancer; 2003 May; 97(9):2212-7. PubMed ID: 12712473 [TBL] [Abstract][Full Text] [Related]
23. Prognostic relevance of circulating matrix metalloproteinase-2 in acute myeloid leukaemia patients. Aref S; Osman E; Mansy S; Omer N; Azmy E; Goda T; El-Sherbiny M Hematol Oncol; 2007 Sep; 25(3):121-6. PubMed ID: 17497745 [TBL] [Abstract][Full Text] [Related]
24. Clinical and laboratory features of the myeloid and lymphocytic leukemias. Rowe JM Am J Med Technol; 1983 Feb; 49(2):103-9. PubMed ID: 6573132 [TBL] [Abstract][Full Text] [Related]
25. [Factors influencing outcome in children with acute lymphoblastic leukemia (author's transl)]. Javier G; Ortega JJ; Domingo A; Sáenz A; Tusell J An Esp Pediatr; 1976 Jun; 9(4 Suppl):35-40. PubMed ID: 1066068 [TBL] [Abstract][Full Text] [Related]
26. [Analysis of prognostic factors in patients with refractory acute myeloid leukemia]. Zhang Q; Feng R; Liu QF; Liu XL; Xu B; Zheng WY; Meng FY; Zhou SY Di Yi Jun Yi Da Xue Xue Bao; 2003 Sep; 23(9):934-6. PubMed ID: 13129725 [TBL] [Abstract][Full Text] [Related]
27. [Development and prognostic significance of cytochemical aspects in acute leukemia]. Zittoun R; Cadiou M; Smadja R; de Langenhagen B; Bilski-Pasquier G; Bousser J Pathol Biol (Paris); 1969; 17(11):623-8. PubMed ID: 4906282 [No Abstract] [Full Text] [Related]
28. Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up. Palandri F; Castagnetti F; Testoni N; Luatti S; Marzocchi G; Bassi S; Breccia M; Alimena G; Pungolino E; Rege-Cambrin G; Varaldo R; Miglino M; Specchia G; Zuffa E; Ferrara F; Bocchia M; Saglio G; Pane F; Alberti D; Martinelli G; Baccarani M; Rosti G; Haematologica; 2008 Dec; 93(12):1792-6. PubMed ID: 18838477 [TBL] [Abstract][Full Text] [Related]
29. [Initial aspects of acute leukemias. Statistical study of 90 cases]. Resegotti L; Rossi M; Infelise V Minerva Med; 1973 May; 64(38):2013-25. PubMed ID: 4515884 [No Abstract] [Full Text] [Related]
30. [Prognostic significance of age and karyotype in the treatment of acute myeloid leukemia: results at our center]. Nahajevszky S; Kapás B; Adám E; Lovas N; Halm G; Gopcsa L; Tamáska J; Poros A Orv Hetil; 2004 Jan; 145(4):167-72. PubMed ID: 14978882 [TBL] [Abstract][Full Text] [Related]
31. Prognostic criteria and staging in ALL in childhood. Hrodek O; Hyniová H Haematologia (Budap); 1976; 10(1):33-9. PubMed ID: 1087623 [TBL] [Abstract][Full Text] [Related]
32. [Differentiation of acute leukemias]. Creutzig U; Schellong G Dtsch Med Wochenschr; 1981 Oct; 106(40):1303-8. PubMed ID: 7023902 [No Abstract] [Full Text] [Related]
33. [Suspected leukemia: what should be done?]. Bucher U; Tschopp L Schweiz Med Wochenschr; 1981 Mar; 111(13):438-43. PubMed ID: 6940240 [TBL] [Abstract][Full Text] [Related]
34. Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective study. Kornblau SM; Andreeff M; Hu SX; Xu HJ; Patel S; Theriault A; Koller C; Kantarjian H; Estey E; Deisseroth AB; Benedict WF Clin Cancer Res; 1998 Aug; 4(8):1955-63. PubMed ID: 9717825 [TBL] [Abstract][Full Text] [Related]
36. Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital. Ghosh S; Shinde SC; Kumaran GS; Sapre RS; Dhond SR; Badrinath Y; Ansari R; Kumar A; Mahadik S; Chougule AB; Nair CN Indian J Cancer; 2003; 40(2):71-6. PubMed ID: 14716122 [TBL] [Abstract][Full Text] [Related]
37. Elevated lactate dehydrogenase is an adverse predictor of outcome in HLA-matched sibling bone marrow transplant for acute myelogenous leukemia. Kalaycio M; Rybicki L; Pohlman B; Dean R; Sweetenham J; Andresen S; Sobecks R; Sekeres MA; Advani A; Brown S; Bolwell B Bone Marrow Transplant; 2007 Oct; 40(8):753-8. PubMed ID: 17700600 [TBL] [Abstract][Full Text] [Related]
38. [DNA aneuploidy in children with acute leukemia: II. Correlation with the phenotype of blasts, clinical picture and course of disease]. Ritter J; Hiddemann W; Wörmann B; Büchner T; Schellong G Klin Padiatr; 1985; 197(3):221-4. PubMed ID: 3892150 [TBL] [Abstract][Full Text] [Related]
39. Outcome of patients with acute myelogenous leukemia after second salvage therapy. Giles F; O'Brien S; Cortes J; Verstovsek S; Bueso-Ramos C; Shan J; Pierce S; Garcia-Manero G; Keating M; Kantarjian H Cancer; 2005 Aug; 104(3):547-54. PubMed ID: 15973664 [TBL] [Abstract][Full Text] [Related]
40. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF). Estey EH; Kantarjian HM; O'Brien S; Kornblau S; Andreeff M; Beran M; Pierce S; Keating M Cytokines Mol Ther; 1995 Mar; 1(1):21-8. PubMed ID: 9384660 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]